Hexosaminidase A and Total Hexosaminidase
Hexosaminidase A is a critical lysosomal enzyme responsible for the degradation of GM2 gangliosides, a type of glycosphingolipid abundant in neuronal cell membranes. Proper function of this enzyme prevents the accumulation of GM2 gangliosides, which can otherwise become neurotoxic.
Hexosaminidase A is encoded by the HEXA gene, and mutations or pathogenic variants in this gene result in deficient enzymatic activity, leading to the progressive accumulation of GM2 gangliosides within neuronal lysosomes. This condition manifests as an autosomal recessive neurodegenerative disorder known as Tay-Sachs Disease (TSD). TSD has three distinct clinical phenotypes: infantile, juvenile, and adult-onset. The infantile form is the most common and severe, typically presenting within the first 6 months of life. Clinical manifestations include progressive loss of motor skills, hypotonia, exaggerated startle response, cherry-red macular spots on fundoscopic examination, seizures (particularly after 12 months of age), and marked neurodevelopmental regression starting around 8–10 months of age. Most affected children unfortunately succumb by age 2–3 years, with only rare survival beyond early childhood.
The diagnosis of Tay-Sachs Disease involves measuring the enzymatic activity of hexosaminidase A and is confirmed genetically through HEXA gene mutation analysis using PCR or next-generation sequencing (NGS). Testing is also employed for carrier screening purposes, particularly among individuals of Ashkenazi Jewish descent due to their higher carrier frequency.
- Diagnosis of Tay-Sachs Disease (infantile, juvenile, and adult-onset forms)
- Carrier detection and genetic counseling, particularly in populations at increased risk (e.g., Ashkenazi Jewish heritage)
- Prenatal diagnosis for at-risk pregnancies
Decreased Hexosaminidase A enzyme activity indicates:
- Affected status (low to absent enzyme activity): Confirmatory for Tay-Sachs Disease.
- Carrier status (moderately reduced enzyme activity): Indicates genetic carrier state.
Normal or Elevated Hexosaminidase A enzyme activity indicates:
- Absence of Tay-Sachs Disease; however, elevated levels are clinically insignificant and do not correlate with disease severity or presence.
High Hexosaminidase A activity correlates with the diagnosis and severity of Tay Sachs disease.
Normal: 1.23-2.59 U/L
Indeterminate: 1.16-1.22 U/L
Carrier: 0.58-1.15 U/L
Serum (SST tube).
Stability
- Ambient: Not recommended
- Refrigerated: 7 days
- Frozen: Preferred, stable for up to 180 days
- Proc Natl Acad Sci U S A. 1989 Apr;86(7):2413-7. [PMID: 2522660]
- Genet Med. 2008;10(1):54-6. [PMID: 18197057]
- Annu Rev Biochem. 2019;88:461-485. [PMID: 31220974]
- Methods Mol Biol. 2018;1804:97-141. [PMID: 29926406]
- Hum Mutat. 1997;9(3):195-208. [PMID: 9090523]
- Arch Neurol. 2004;61(9):1466-8. [PMID: 15364698]
- Methods Mol Biol. 2019;1885:233-250. [PMID: 30506202]
- Toro C, Shirvan L, Tifft C. HEXA Disorders. 1999 Mar 11 [Updated 2020 Oct 1]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1218/
- Lui F, Ramani PK, Parayil Sankaran B. Tay-Sachs Disease. [Updated 2024 Oct 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK564432/